Citalopram 20mg ( DrugBank: Citalopram )


1 disease
IDDisease name (Link within this page)Number of trials
6Parkinson disease1

6. Parkinson disease


Clinical trials : 2,307 Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04497168
(ClinicalTrials.gov)
April 1, 202129/7/2020Citalopram as a Posterior Cortical Protective Therapy in Parkinson DiseaseCitalopram as a Posterior Cortical Protective Therapy in Parkinson DiseaseParkinson DiseaseDrug: Citalopram 20mg;Drug: PlaceboUniversity of MichiganNational Institute on Aging (NIA)Recruiting65 YearsN/AAll58Phase 2United States